PURPOSE: To present a case of a full-thickness macular hole closure in a patient with Behcet uveitis. DESIGN: A 23-year-old-male patient with Behcet Disease had clinically inactive uveitis with topical steroids, oral azathiopurine and cyclosporine until he developed a retinal infiltrate in the left eye which evolved into a full-thickness macular hole during the follow-up. METHODS: Strict control of inflammation and subsequent vitrectomy was planned. Meanwhile another attack of panuveitis developed in the left eye and subcutaneous Interferon alfa-2b interferon treatment was initiated. RESULTS: After 2 months, the patient was clinically inactive with complete closure of the macular hole. CONCLUSIONS: Strict control of inflammation may result in closure of the macular hole and avoid the need for vitrectomy.
PURPOSE: To present a case of a full-thickness macular hole closure in a patient with Behcet uveitis. DESIGN: A 23-year-old-male patient with Behcet Disease had clinically inactive uveitis with topical steroids, oral azathiopurine and cyclosporine until he developed a retinal infiltrate in the left eye which evolved into a full-thickness macular hole during the follow-up. METHODS: Strict control of inflammation and subsequent vitrectomy was planned. Meanwhile another attack of panuveitis developed in the left eye and subcutaneous Interferon alfa-2b interferon treatment was initiated. RESULTS: After 2 months, the patient was clinically inactive with complete closure of the macular hole. CONCLUSIONS: Strict control of inflammation may result in closure of the macular hole and avoid the need for vitrectomy.
Authors: Natalia F Callaway; Marco A Gonzalez; Yoshihiro Yonekawa; Lisa J Faia; Efrem D Mandelcorn; Rahul N Khurana; Mohamed G A Saleh; Phoebe Lin; Lucia Sobrin; Thomas A Albini Journal: Retina Date: 2018-09 Impact factor: 4.256